Literature DB >> 33187150

Trends of Late Presentation to Care in Patients with Chronic Hepatitis C during a 10-Year Period in Croatia.

Neven Papic1,2, Leona Radmanic3, Davorka Dusek1,2, Ivan Kurelac1, Snjezana Zidovec Lepej3, Adriana Vince1,2.   

Abstract

Late presentation to care is the major obstacle to receiving treatment for chronic hepatitis C (CHC). Our aim was to analyze the prevalence and trends of late presenters (LP) at first consultations in Croatia during a 10-year period. This retrospective cross-sectional study included all adult CHC patients (n = 854) entering specialist medical care at the University Hospital for Infectious Diseases Zagreb between 2009 and 2018. LP was defined as liver stiffness measurement ≥ 9.5 kPa or biopsy METAVIR F ≥ 3. During the study period, mean patients' age increased from 37 to 52 years while HCV genotype distribution changed leading to the replacement of genotype 1b with 1a (g1b 32% to 21%; g1a 19% to 38%). A total of 320 (37.4%) were LP; they were older (47.5, IQR 40.5-57.6), and more commonly infected with g1b (34.1%) and g3 (42.5%). The prevalence of LP significantly increased from 31.9% in 2009 to 46.5% in 2018. Late presentation for care of CHC is increasing in Croatia suggesting a gap of diagnosing strategies in patients over 50 years.

Entities:  

Keywords:  HCV; chronic hepatitis C; end stage liver disease; late presenters; liver cirrhosis

Year:  2020        PMID: 33187150     DOI: 10.3390/idr12030016

Source DB:  PubMed          Journal:  Infect Dis Rep        ISSN: 2036-7430


  3 in total

Review 1.  Races of small molecule clinical trials for the treatment of COVID-19: An up-to-date comprehensive review.

Authors:  Suwen Hu; Songwei Jiang; Xiang Qi; Renren Bai; Xiang-Yang Ye; Tian Xie
Journal:  Drug Dev Res       Date:  2021-11-11       Impact factor: 5.004

2.  Laboratory Profile of COVID-19 Patients with Hepatitis C-Related Liver Cirrhosis.

Authors:  Bianca Cerbu; Mirela Loredana Grigoras; Felix Bratosin; Iulia Bogdan; Cosmin Citu; Adrian Vasile Bota; Madalina Timircan; Melania Lavinia Bratu; Mihaela Codrina Levai; Iosif Marincu
Journal:  J Clin Med       Date:  2022-01-27       Impact factor: 4.241

Review 3.  HCV Elimination in Central Europe with Particular Emphasis on Microelimination in Prisons.

Authors:  Robert Flisiak; Dorota Zarębska-Michaluk; Egle Ciupkeviciene; Sylvia Drazilova; Sona Frankova; Ivica Grgurevic; Bela Hunyady; Peter Jarcuska; Limas Kupčinskas; Michael Makara; Gunita Saulite-Vanaga; Marieta Simonova; Jan Sperl; Ieva Tolmane; Adriana Vince
Journal:  Viruses       Date:  2022-02-26       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.